YHYusuf Helo

Yusuf Helo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yusuf Helo has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A new approach to modeling the microdosimetry of proton therapy beams

    by Ramin Abolfath, Yusuf Helo, David J. Carlson, Robert Stewart, David Grosshans, Radhe Mohan

    Introduction: To revisit the formulation of the mean chord length in microdosimetry and replace it by the particle mean free path appropriate for modelings in radiobiology.Methods: We perform a collision‐by‐collision followed by event‐by‐event Geant4 Monte Carlo simulation and calculate double‐averaged stepping length, 〈〈l〉〉, for a range of target sizes from mm down to μm and depth in water. We consider 〈〈l〉〉 to represent the particle mean free path.Results: We show that 〈〈l〉〉 continuously drops as a function of depth and asymptotically saturates to a minimum value in low energies, where it exhibits a universal scaling behavior, independent of particle nominal beam energy. We correlate 〈〈l〉〉 to linear density of DNA damage, complexities of initial lethal lesions and illustrate a relative difference between predictive RBEs in model calculations using mean chord length vs the proposed mean free path. We demonstrate consistency between rapid increase in RBE within and beyond the Bragg peak and 〈〈l〉〉, a decreasing function of depth.Discussion and conclusion: An interplay between localities in imparted energy at nanometer scale and subsequent physio‐chemical processes, causalities and pathways in DNA damage requires substitution of geometrical chord length of cell nuclei by mean‐free path of proton and charged particles to account for a mean distance among sequential collisions in DNA materials. To this end, the event averaging over cell volume in the current microdosimetry formalism must be superseded by the collision averaging scored within the volume. The former, is fundamentally a global attribute of the cell nuclei surfaces and boundaries and is characterized by their membrane diameters, hence such global indices are not appropriate to quantitatively represent the radiobiological strength of the particles and their RBE variabilities that is associated with the sensitivities to local structure of the collisions and their spatio‐temporal collective patterns in DNA materials.


  • Renormalization of radiobiological response functions by energy loss fluctuations and complexities in chromosome aberration induction: deactivation theory for proton therapy from cells to tumor control

    by Ramin Abolfath, Yusuf Helo, Lawrence Bronk, Alejandro Carabe, David Grosshans, Radhe Mohan

    We employ a multi-scale mechanistic approach built upon our recent phenomenological/computational methodologies [R. Abolfath et al., Sci. Rep. 7, 8340 (2017)] to investigate radiation...


  • Open Access

    Quality assurance in proton beam therapy using a plastic scintillator and a commercially available digital camera

    by Mansour Almurayshid, Yusuf Helo, Andrzej Kacperek, Jennifer Griffiths, Jem Hebden, Adam Gibson

    Purpose: In this article, we evaluate a plastic scintillation detector system for quality assurance in proton therapy using a BC‐408 plastic scintillator, a commercial camera, and a computer.Methods: The basic characteristics of the system were assessed in a series of proton irradiations. The reproducibility and response to changes of dose, dose‐rate, and proton energy were determined. Photographs of the scintillation light distributions were acquired, and compared with Geant4 Monte Carlo simulations and with depth‐dose curves measured with an ionization chamber. A quenching effect was observed at the Bragg peak of the 60 MeV proton beam where less light was produced than expected. We developed an approach using Birks equation to correct for this quenching. We simulated the linear energy transfer (LET) as a function of depth in Geant4 and found Birks constant by comparing the calculated LET and measured scintillation light distribution. We then used the derived value of Birks constant to correct the measured scintillation light distribution for quenching using Geant4.Results: The corrected light output from the scintillator increased linearly with dose. The system is stable and offers short‐term reproducibility to within 0.80%. No dose rate dependency was observed in this work.Conclusions: This approach offers an effective way to correct for quenching, and could provide a method for rapid, convenient, routine quality assurance for clinical proton beams. Furthermore, the system has the advantage of providing 2D visualization of individual radiation fields, with potential application for quality assurance of complex, time‐varying fields.


  • A simulation study of spectral Čerenkov luminescence imaging for tumour margin estimation

    by Nick Calvert, Yusef Helo, Thomy Mertzanidou, David S. Tuch, Simon R. Arridge, Danail Stoyanov

    Breast cancer is the most common cancer in women in the world. Breast-conserving surgery (BCS) is a standard surgical treatment for breast cancer with the key objective of removing breast tissue, maintaining a negative surgical margin and providing a good cosmetic outcome. A positive surgical margin, meaning the presence of cancerous tissues on the surface of the breast specimen after surgery, is associated with local recurrence after therapy. In this study, we investigate a new imaging modality based on Cerenkov luminescence imaging (CLI) for the purpose of detecting positive surgical margins during BCS. We develop Monte Carlo (MC) simulations using the Geant4 nuclear physics simulation toolbox to study the spectrum of photons emitted given 18F-FDG and breast tissue properties. The resulting simulation spectra show that the CLI signal contains information that may be used to estimate whether the cancerous cells are at a depth of less than 1 mm or greater than 1 mm given appropriate imaging system design and sensitivity. The simulation spectra also show that when the source is located within 1 mm of the surface, the tissue parameters are not relevant to the model as the spectra do not vary significantly. At larger depths, however, the spectral information varies significantly with breast optical parameters, having implications for further studies and system design. While promising, further studies are needed to quantify the CLI response to more accurately incorporate tissue specific parameters and patient specific anatomical details. © (2017) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.

  • Open Access

    Bayesian Estimation of Intrinsic Tissue Oxygenation and Perfusion From RGB Images

    by Geoffrey Jones, Neil T. Clancy, Yusuf Helo, Simon Arridge, Daniel S. Elson, Danail Stoyanov

    Multispectral imaging (MSI) can potentially assist the intra-operative assessment of tissue structure, function and viability, by providing information about oxygenation. In this paper, we present a novel technique for recovering intrinsic MSI measurements from endoscopic RGB images without custom hardware adaptations. The advantage of this approach is that it requires no modification to existing surgical and diagnostic endoscopic imaging systems. Our method uses a radiometric color calibration of the endoscopic camera's sensor in conjunction with a Bayesian framework to recover a per-pixel measurement of the total blood volume (THb) and oxygen saturation (SO 2 ) in the observed tissue. The sensor's pixel measurements are modeled as weighted sums over a mixture of Poisson distributions and we optimize the variables SO 2 and THb to maximize the likelihood of the observations. To validate our technique, we use synthetic images generated from Monte Carlo physics simulation of light transport through soft tissue containing sub-surface blood vessels. We also validate our method on in vivo data by comparing it to a MSI dataset acquired with a hardware system that sequentially images multiple spectral bands without overlap. Our results are promising and show that we are able to provide surgeons with additional relevant information by processing endoscopic images with our modeling and inference framework.


  • The physics of Cerenkov light production during proton therapy

    by Y Helo, A Kacperek, I Rosenberg, G Royle, A P Gibson

    There is increasing interest in using Cerenkov emissions for quality assurance and in vivo dosimetry in photon and electron therapy. Here, we investigate the production of Cerenkov light during proton therapy and its potential applications in proton therapy. A primary proton beam does not have sufficient energy to generate Cerenkov emissions directly, but we have demonstrated two mechanisms by which such emissions may occur indirectly: (1) a fast component from fast electrons liberated by prompt gamma (99.13%) and neutron (0.87%) emission; and (2) a slow component from the decay of radioactive positron emitters. The fast component is linear with dose and doserate but carries little spatial information; the slow component is non-linear but may be localised. The properties of the two types of emission are explored using Monte Carlo modelling in GEANT4 with some experimental verification. We propose that Cerenkov emissions could contribute to the visual sensation reported by some patients undergoing proton therapy of the eye and we discuss the feasibility of some potential applications of Cerenkov imaging in proton therapy.


  • Imaging Cerenkov emission as a quality assurance tool in electron radiotherapy

    by Yusuf Helo, Ivan Rosenberg, Derek D’souza, Lindsay MacDonald, Robert Speller, Gary Royle, Adam Gibson

    A new potential quality assurance (QA) method is explored (including assessment of depth dose, dose linearity, dose rate linearity and beam profile) for clinical electron beams based on imaging Cerenkov light. The potential of using a standard commercial camera to image Cerenkov light generated from electrons in water for fast QA measurement of a clinical electron beam was explored and compared to ionization chamber measurements. The new method was found to be linear with dose and independent of dose rate (to within 3%). The uncorrected practical range measured in Cerenkov images was found to overestimate the actual value by 3 mm in the worst case. The field size measurements underestimated the dose at the edges by 5% without applying any correction factor. Still, the measured field size could be used to monitor relative changes in the beam profile. Finally, the beam-direction profile measurements were independent of the field size within 2%. A simulation was also performed of the deposited energy and of Cerenkov production in water using GEANT4. Monte Carlo simulation was used to predict the measured light distribution around the water phantom, to reproduce Cerenkov images and to find the relation between deposited energy and Cerenkov production. The camera was modelled as a pinhole camera in GEANT4, to attempt to reproduce Cerenkov images. Simulations of the deposited energy and the Cerenkov light production agreed with each other for a pencil beam of electrons, while for a realistic field size, Cerenkov production in the build-up region overestimated the dose by +8%.


  • Cerenkov optical emissions in particle radiotherapy

    by Yusuf Helo, Ivan Rosenberg, Andrzej Kacperek, Derek D’souza, Lindsay MacDonald, Emma Dixon, Robert Speller, Gary Royle, Adam Gibson

    We present simulations and measurements of Cerenkov optical radiation in electron and proton radiotherapy. Photographs of Cerenkov emission from electrons can predict the range to ±1.5mm, but underestimate superficial dose.